Chapter 9: Infection

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to The Deep Dive.

We're here to unpack compelling sources and arm you with, well, knowledge.

You know, in medicine we hear a lot about amazing breakthroughs.

But there's this constant unseen battle always going on.

The fight against infectious diseases.

They're a huge threat.

Not just new bugs popping up, but old ones coming back.

And maybe the scariest part, microbes becoming resistant to our best drugs.

So today we're taking a deep dive into infection.

We're pulling our insights straight from a core text, Understanding Pathophysiology, seventh edition.

Our mission, to really get a handle on this dynamic between us and these

tiny invaders.

How infections start, the different kinds of agents, and crucially how we fight back.

That's right.

And this is for you, our listener.

Maybe you're a college student prepping for an exam or maybe you're just really curious about health.

We want this deep dive to be a clear step -by -step guide.

We'll break down the tricky concepts, you know, mechanism by mechanism, use real examples to make it stick.

And you won't need any visuals.

We'll paint the picture with words.

Yeah, think of it like your shortcut to getting up to speed.

Give you those aha moments about why infections are still such a big deal.

All right, let's jump in.

First up,

microorganisms are constant companions.

The human body is like a five -star resort for them, plenty of food, perfect temperature, moisture.

Exactly.

It's prime real estate.

But here's the kicker.

Only a tiny fraction of these microbes actually make us sick.

We live with this huge community of resident microbes.

It's called the normal human microbiome.

They're all over skin, mouth, gut, respiratory tract, genital tract, everywhere.

And take the gut bacteria, for example.

They don't just freeload.

They make enzymes that help us digest things we can't break down ourselves.

They produce stuff that fights off harmful bacteria.

And they even make vitamins for us like vitamin K and some B vitamins.

It's a partnership.

So it's definitely not all bad news.

It's quite a varied relationship.

The chapter actually outlines five key types.

Understanding these is, well, essential.

You've got symbiosis.

Good for us.

Neutral for the microbe.

Mutualism.

That's the win -win.

Good for both.

Commensalism.

Good for the microbe.

Neutral for us.

Then pathogenicity.

Good for the microbe, but bad for us.

That's disease.

And finally, opportunism.

This is where it gets interesting, isn't it?

It really is.

Normally harmless microbes turn bad.

Why?

Because our defenses drop or they end up somewhere they shouldn't be.

Exactly.

That balance is key.

Our skin, our mucous membranes, our immune system, they all keep this microbiome in check.

But if those defenses weaken, or if something like antibiotics wipes out some of our good bacteria.

Then the opportunists see their chance.

Precisely.

They can overgrow and cause trouble.

Think C2bif causing severe diarrhea after antibiotics.

Or Candida albicans, yeast infections getting out of control when immunity is low.

It's taking advantage of an opportunity.

Okay.

So if only a few microbes cause disease, how do they actually do it?

What's the playbook for infection?

It's a multi -step process, like a campaign.

It starts with encounter and transmission,

then colonization setting up shop.

After that comes invasion, possibly dissemination spreading out and finally causing actual cellular or tissue damage.

Right.

And the culprits, the pathogens themselves, they're a really diverse bunch.

The book lists them out.

We're talking tiny viruses, larger bacteria, fungi, protozoa, even worms, helmets,

some huge.

Yeah, from nanometers to meters.

It's quite a scale.

And they live differently too.

Some have to get inside ourselves.

Others are fine living outside.

That changes everything.

It does.

So step one is encounter and transmission.

Where did they come from?

They could be endogenous already living on or in us as part of that microbiome.

Like a sleeper agent?

Kind of.

Or they're exogenous coming from outside.

Contaminated water, food, another person, animals, insects,

lots of sources.

And how do they get from the source to us?

Transmission.

There's direct transmission.

That can be vertical mother to child, like Listeria across the placenta.

Or group B strep during birth.

Right.

Or staph through breast milk.

And then horizontal person to person, maybe body fluids like with HIV or gonorrhea.

And don't forget zoonotic directly from animals like Giordia.

Okay.

Then there's indirect transmission.

This is touching infected objects, towels, toys, or breathing in droplets, colds, pneumonia,

eating or drinking contaminated stuff, gastroenteritis, cholera,

or inoculation.

Like a mosquito bite delivering malaria or stepping on a rusty nail and getting tetanus.

So once they've made contact, they need to colonize.

That means sticking around and multiplying.

They have to compete with our normal microbes and resist our local defenses.

And the number needed to start an infection, the minimum infective dose varies massively.

Admission norovirus, just 10 to 100 particles, that's tiny.

Incredibly low.

Compare that to cholera needing maybe hundreds of millions of bacteria.

And adherence is crucial here, sticking to our cells so they don't get washed away, like Velcro.

Like how cold viruses latch onto our respiratory tract cells.

Exactly.

But we fight back, right?

Our immune system isn't just sitting there.

Oh, absolutely not.

But pathogens have counter moves.

The book highlights some pretty clever ways they resist us.

Like what?

Well, some produce toxins that kill our immune cells, phagocytes.

Staff and Strep do this.

Others make enzymes, proteases that chew up our antibodies like IgA.

Niceria gonorrhea is good at that.

Right.

And some even play dress up.

Yeah.

Mimicking our own cells.

Yeah.

Mimicking self -antigens.

Group A Strep's M protein is a classic example.

Our immune system targets it, but then gets confused and can attack our own heart tissue, leading to rheumatic heart disease.

It's tragic collateral damage.

And the shapeshifters.

Like flu and HIV.

Antigenic variation.

They constantly change their surface proteins, their look.

Our immune system learns to recognize one look, but then the virus changes, delaying the response.

Very sneaky.

Okay, this sounds tough enough, but then you mentioned biofilms.

That sounds ominous.

They're a major challenge.

Imagine these organized communities like little microbial cities, bacteria, maybe fungi too, all embedded in this slimy matrix they build themselves.

Like a protective shield.

Exactly.

It makes them incredibly resistant to antibiotics, to our immune cells.

They're just hunkered down.

You see them a lot on medical implants, catheters, pacemakers, and they're involved in chronic infections like stubborn ear infections or diabetic foot ulcers.

Very hard to invasion or penetration.

Crossing those surface barriers, skin, mucous membranes could be direct like that mosquito bite or taking advantage of a cut or wound.

A breach in the defenses.

Precisely.

And once they're through, dissemination, spreading either locally into nearby tissue, or they get into the bloodstream or lymphatic system and travel far and wide.

And the end game is damage.

Cellular or tissue damage can be direct from toxins the pathogen releases, or it can be indirect with the result of our own immune system fighting back, causing inflammation, swelling, scarring, even tissue death and necrosis.

Right.

That gives examples here too, like strep pyogenes causing scarlet fever with exotoxin.

Or clostridium titani and tetanus toxin.

Direct damage.

And then endotoxins from gram -negative bacteria like E.

coli in sepsis

or salmonella in typhoid.

Those are released when the bacteria break down, right?

That's right.

Part of their structure.

Viruses like smallpox cause direct damage just by invading and replicating.

Yep.

And the indirect damage often involves our immune system.

Immune complexes from Hep B, causing kidney disease.

Or the immune response in TB, causing lung damage cell -mediated immunity.

It's often our own response causing the symptoms.

It is.

So beyond these steps, there are other factors defining a pathogen's personality, if you will.

Communicability, how easily does it spread?

Measles, super high.

Immunogenicity, how well does it trigger an immune response?

Infectivity, how good is it at invading and multiplying?

Its specific mechanism of action, its overall pathogenicity ability to cause disease.

Portal of entry, how it gets in.

Toxogenicity, does it make toxins?

And virulence, how severe is the disease it causes?

Rabies is highly virulent.

Measles, low virulence, but highly communicable.

That's a lot of virulence.

It really highlights how different these microbes are.

It does.

And thinking about all this helps us classify how diseases spread in populations.

Ah, right.

The endemic, epidemic, pandemic distinctions.

Exactly.

Endemic means it's consistently present at relatively high rates in a population, like chronic hepatitis in the US.

Epidemic is when you get a sudden surge.

Way more cases than usual in that population.

And pandemic is an epidemic that goes global, or at least covers a huge area, like a continent.

Okay, got it.

And finally, the stages we go through when we do get infected.

Right, the clinical stages.

It's a timeline.

First, the incubation period.

From exposure to the first hint of symptoms.

The microbes are multiplying, but quietly.

Could be hours, could be years.

Then the prodromal stage.

You start feeling a bit off malaise, fatigue.

Still pretty vague symptoms of pathogens are still multiplying.

Then comes the invasion or acute illness period.

This is when the pathogen is really going for it, multiplying rapidly, spreading.

Our immune system kicks into high gear, inflammation ramps up, symptoms become more specific and often more severe.

And hopefully after that peak.

Condolescence, recovery.

The immune system gets the upper hand, clears the infection, symptoms fade, though sadly it could also be fatal, or the disease might enter a latent phase.

And the really important point, you can be contagious during any of these stages.

Absolutely.

Even during incubation, before you feel sick at all.

That's crucial for understanding spread.

Wow.

Okay, that framework is super helpful.

Now let's dive deeper into the specific types of troublemakers.

Starting with bacteria.

Okay, bacteria.

Prokaryotes, single cells, no nucleus.

Very common causes of disease.

They come in different shapes.

Spheres, coquette, rods, bacilli, spirals, speartates.

Some need oxygen, some don't.

Some can move, some can't.

And a key classification is gram staining.

The book has a figure showing this.

Imagine staining them.

Gram positive bacteria have a really thick outer layer, peptidoglycan.

It holds the stain, so they look dark purple.

Gram negative bacteria have a thinner peptidoglycan layer, plus an outer membrane.

This outer membrane has that LPS lipopolysaccharide, the endotoxin.

They don't hold the main stain as well, so they appear light pink after counterstaining.

This difference is fundamental.

And they have those virulence factors, we mentioned, tools to help them infect us.

Right.

Peely for sticking, flagella for swimming,

capsules to hide from immune cells, enzymes to invade tissues, and toxins.

Let's talk more about those toxins.

You mentioned exotoxins and endotoxins.

What's the key difference?

Good question.

The book lays it out nicely in a table.

Exotoxins are proteins actively secreted by the bacteria, both gram positive and gram negative.

They directly harm our cells, maybe punch holes in membranes or mess with cell functions.

They're potent.

They strongly provoke our immune system, highly antedemic.

And we can make vaccines against them by creating harmless versions called toxoids.

Think tetanus or diphtheria shots.

And some are incredibly potent, like botulinum toxin.

The most poisonous known, yes, causes paralysis.

And Staph aureus is a master of making different exotoxins, causing different diseases,

skin syndromes, food poisoning,

toxic shock.

Okay.

So those are exotoxins, the secreted weapons.

What about endotoxins?

Endotoxins are different.

Specifically, it's that LPS component of the outer membrane of gram negative bacteria only.

They aren't actively secreted.

They're released when the bacteria grows or dies and breaks apart.

They are powerfully pyrogenic.

They cause fever by triggering a massive inflammatory response.

They don't trigger a strong, specific antibody response.

So making vaccines against them is hard.

And crucially, antibiotics killing the bacteria can actually release more endotoxin initially.

That's tricky.

And this distinction matters hugely in serious infections, right?

Like sepsis.

Critically.

Bacteremia just means bacteria are present in the blood.

But sepsis or septicemia means they're actively growing there and releasing large amounts of toxins.

Both exotoxins and endotoxins.

Yes.

These toxins trigger a cytokine storm and overproduction of inflammatory signals like TNF -alpha, IL -1, IL -6, plus reactive oxygen species.

This whole cascade causes fever, activates platelets, leading to clotting problems, makes capillaries super leaky.

Leading to low blood pressure.

Hypotension, yes.

And potentially septic shock, where organs start failing due to lack of blood flow.

It's life -threatening.

A really dangerous systemic meltdown.

Okay.

Let's shift gears to viruses.

Very different beasts.

Very different.

Obligatory intracellular microbes.

They have to get inside our cells to replicate.

They're basically just genetic material, DNA or RNA, wrapped in a protein coat, the capsid.

They need a permissive host cell.

One that can't fight them off easily.

The book illustrates the steps, right?

Like a hijacking operation.

Pretty much.

Step one, attachment.

The virus locks onto a specific receptor on the cell surface.

That determines which cells it can infect.

Step two, penetration.

Getting inside, maybe by being engulfed or by fusing its membrane with the cells.

Step three, uncoating.

The capsid breaks down, releasing the viral genes.

Then the takeover.

Step four, replication.

The virus hijacks the cell's machinery, its ribosomes, enzymes to make viral proteins and copy its own genes.

Step five, assembly.

New virus particles are put together.

Step six, release.

The new viruses get out, either by bursting the cell open or lysis, or by budding off the surface.

Sometimes taking a bit of the cell membrane with them is an envelope, right?

Like HIV or flu?

Exactly.

Extra protection.

And the damage they cause?

It's not just hijacking, is it?

No.

They can really wreck the cell, stop its normal functions, disrupt internal structures, make cells fuse together into weird giant cells.

They can change the cell surface so the immune system attacks it, or even turn the cell cancerous, like HPV.

And they can pave the way for bacterial infections, too.

Yes, by damaging tissues like in the lungs with flu or RSV, making it easier for bacteria to move in.

And that viral latency trick, hiding out.

A brilliant survival strategy.

Varicella zoster, the chicken pox virus, hides in nerve cells for years, then reactivates as shingles.

Herpes viruses do this, too.

And the constant changing antigenic variation.

Especially with flu.

Influenza A is the classic example.

It has those surface proteins, HA and NA.

Our antibodies target these.

So small changes year to year.

That's antigenic drift.

Right.

Minor mutations, maybe combinations of strains.

That's why the flu shot changes each year.

You might have some partial immunity from past infections or shots.

But the big one is antigenic shift.

That's the sudden major change.

When different flu viruses, maybe from birds or pigs mixed with human strains, often in animal hosts, they swap genetic segments and create a totally new subtype.

Our immune systems have never seen it before.

No protection.

And that's when you get pandemics.

Like H1N1 swine flu in 2009.

Exactly.

That's why global surveillance by the CDC and WHO is so critical.

They track these shifts constantly.

And unlike bacteria, viruses don't usually make toxins, right?

The misery is mostly our own immune response.

Largely, yes.

The fever, aches, inflammation that's often our body fighting back against the infected cells or reacting to cell damage.

But the outcome can still be severe illness or death, like from flu pneumonia or HIV complication.

Okay.

Moving on to fungi.

Bigger, more complex than bacteria or viruses.

Yes.

They're eukaryotes, like our cells, but with thick cell walls.

The book shows two main forms.

Single -celled yeast, sort of round or oval.

And multicellular molds, which grow as filaments called hyphae.

Like threads.

Exactly.

And some are dimorphic.

They can switch between yeast and mold forms.

Importantly, their cell walls are different from bacteria.

No peptide of lichen.

That's why antibacterial drugs like penicillin don't work on them.

Fungal infections are called mycosis.

Can be superficial, like ringworm.

Caused by dermatophytes, yeah.

Skin, hair, nails.

Or they can be deep opportunistic infections.

Right.

Fungi cause disease by adapting to us, and our immune cells, phagocytes, and T cells are key to controlling them.

So people with weakened immune systems, low white cell counts are really vulnerable.

And how do they cause damage?

Directly with enzymes that degrade tissue.

And indirectly by triggering inflammation.

Plus, some molds produce mycotoxins in food, like aflatoxins from aspergillus on nuts or grains, which can be carcinogenic or cause neurological issues if ingested.

You mentioned candida albicans earlier.

That's a really common one.

The most common cause of human fungal infections.

It's normally a harmless yeast living in our microbiome gut, mouth, vagina, skin.

An opportunist waiting for an opening.

Exactly.

If the local environment changes, or our defenses drop maybe after antibiotics kill off competing bacteria, candida can overgrow, leading to thrush in the mouth, or vaginal yeast infections.

But it can get much worse in immunocompromised people.

Yes, definitely.

Especially if they have neutropenia, low neutrophils.

Disseminated candida infection can spread through the blood stream.

It's a huge risk for cancer patients, transplant recipients, people with AIDS.

It can seed infections in the kidneys, brain, liver, heart, causes persistent fever, sepsis -like symptoms, clotting issues, and carries about a 30 % mortality rate.

Very serious.

Okay.

Last group.

Parasites.

A really mixed bag here.

From tiny protozoa to large worms.

Right.

The relationship is purely parasitic.

They benefit.

We suffer.

Helminths are the worms.

Hookworms, roundworms, tapeworms living in the gut or tissues.

Protozoa are single -celled eukaryotes.

Think plasmodium causing malaria, Entamoeba causing amoebic dysentery, Giardia causing diarrhea, Trypanosoma causing sleeping sickness.

Some of these sound exotic, but others are common even here, right?

Well, things like toxoplasma and trichomonas are relatively common in the U .S.

Malaria is less so here, but globally, it's massive.

One of the most common infections worldwide.

And transmission is often through vectors.

For many protozoa, yes.

Mosquitoes for malaria, sitzy flies for sleeping sickness, sand fleas for leishmaniasis, but contaminated food and water are also major outs for things like Entamoeba and Giardia.

And the damage they cause.

Is it direct attack?

Often indirect or through enzyme release during invasion.

Take malaria again.

Plasmodium multiplies inside red blood cells.

When they burst, releasing more parasites, that causes anemia.

It also triggers cytokines, causing those cyclic fevers, chills, sweats, aches.

Severe cases can lead to lung problems or neurological issues if infected red cells clog brain capillaries.

It can be fatal.

Most tissue damage comes from enzymes released to help them invade.

Okay, so we've covered the Rogues Gallery.

How do we fight back?

Antibiotics have been the miracle drugs, haven't they?

They really revolutionize medicine since WWII.

Natural products mostly.

Some kill bacteria, bactericidal.

Others just stop them growing bacteriostatic.

They work in clever ways, blocking cell wall building, stopping protein synthesis, messing with DNA replication,

interfering with metabolism like folic acid production.

The miracle is fading.

Antibiotic resistance.

It's one of the biggest public health crises we face.

Millions of resistant infections, thousands of deaths just in the US each year.

And it's often resistance to multiple drugs, leaving very few options.

The CDC flagged some urgent threats years ago.

C.

diff.

CRE bacteria resistant to carbapenems.

Carbapenems are often the last line of defense.

Drug resistant gonorrhea.

And we see resistance in MRSA, pneumococcus, salmonella, even fungi like candida and malaria parasites.

It's widespread.

It is.

And the mechanisms bacteria use to become resistant are fascinating in a scary way.

The book shows several.

One,

they can share resistance genes between themselves, like trading cheat codes.

Horizontal gene transfer spreads it fast.

Two, they make enzymes that destroy the antibiotic.

Beta -lactamase breaking down penicillin is the classic example.

Three, other enzymes chemically modify the antibiotic so it doesn't work anymore.

Four, they have efflux pumps, little pumps in their membrane that actively spit the antibiotic back out.

Five, they can change their cell wall so the antibiotic can't get in or bind properly.

Six, they can alter the target inside the cell that the antibiotic usually attacks so the drug doesn't recognize it.

Multiple strategies.

But why has this happened so fast?

It seems like it exploded.

Several factors contribute.

People not finishing their full course of antibiotics leaves the tougher bugs behind to multiply?

Selective pressure.

Makes sense.

Overuse of antibiotics in general wipes out our good bacteria, creating space for resistant ones to thrive.

And the use in agriculture.

That's a huge concern.

Using antibiotics to promote growth in farm animals could select for resistant bacteria that then transfer to humans through the food chain.

It's a complex web.

It sounds grim, but there are countermeasures.

Prevention is key.

Absolutely.

And while recovering from an infection gives strong immunity, vaccines are a much safer way to get there.

Vaccines use antigens, parts of the pathogen, to train our immune system.

They stimulate antibodies or cellular immunity without causing the actual disease.

The goal is long -lasting protection, safely.

But sometimes one shot isn't enough.

That's where boosters come in.

Exactly.

The initial response might fade.

Boosters give the immune system repeated exposure, building up a large pool of memory cells and sustain high levels of protection.

The CDC keeps updated schedules available for everyone.

And besides vaccines, which give active immunity, there's passive immunotherapy.

Right.

That's giving someone preformed antibodies for immediate, but temporary, protection.

Used for things like hepatitis A and B exposure.

A great example combining both is post -exposure rabies treatment.

You get an injection of rabies antibodies, passive, immediate help, followed by multiple shots of the rabies vaccine active, long -term immunity building.

Best of both worlds.

And new things are being developed too, like monoclonal antibodies?

Yes.

Highly specific therapies.

There's one for RSV, an experimental one for Ebola, alongside vaccines.

Developing new vaccines and targeted antibody therapies is becoming more and more critical as antibiotic resistance grows.

It's a major focus of research.

So connecting all this.

The big takeaway is just how dynamic this all is.

Infectious diseases keep evolving.

Microbes keep adapting.

It's an ongoing arms race.

Absolutely.

Okay.

Let's quickly recap this deep dive.

We looked at the dynamic relationship between us and microbes, our normal microbiome, and how opportunists emerge.

We broke down the process of infection, encounter, colonization, including those tricky biofilms, invasion, spread, and damage.

We learned the four stages.

Incubation, prodromal, acute illness, convalescence, and that contagiousness spans across them.

Then we dove into the pathogens.

Bacteria, with their exotoxins and endotoxins causing things like sepsis.

Viruses, using latency and antigenic shifts like flu.

Fungi, like opportunistic candida.

And parasites, like malaria.

And we hit the critical challenge of antibiotic resistance, its mechanisms, and the factors driving it.

Finally, we looked at our key defenses.

Vaccines for active immunity and passive immunotherapy for immediate help.

This really shows that understanding infection is about appreciating this complex dance.

Microbes, our bodies, our defenses.

It's constantly changing.

It reminds you that knowledge really is power when it comes to health.

So thinking about how microbes constantly adapt,

what do you think is the next big frontier we need to conquer in this invisible war?

Something for you, our listeners, to ponder.

Thank you for joining us on this deep dive into the world of infection.

We hope it's given you a clearer picture and maybe sparked some more questions.

From all of us here at The Deep Dive, thanks for exploring this vital topic with us today.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Pathogenic microorganisms establish complex relationships with human hosts that range from beneficial to destructive, with infection outcomes determined by microbial virulence strategies and host immune capacity. The human microbiome represents a dynamic ecosystem where many microorganisms coexist peacefully through mutualistic partnerships that provide metabolic advantages and support immune system development, while opportunistic pathogens like Clostridium difficile and Candida albicans remain dormant until host barriers weaken or immunosuppression creates permissive conditions. Infections follow a predictable progression beginning with pathogen transmission through direct contact, indirect routes, vertical inheritance, or cross-species zoonotic pathways, followed by microbial attachment and colonization of host tissues, active invasion using specialized virulence factors, systemic spread through bloodstream or lymphatic routes, and ultimately tissue destruction through multiple pathogenic mechanisms. Microorganisms deploy sophisticated immune evasion strategies including toxin generation, catalase production to neutralize reactive oxygen species, proteolytic degradation of protective antibodies, antigenic mimicry to disguise molecular patterns, continuous antigenic variation to escape recognition, and biofilm formation on medical devices that creates protected microbial communities resistant to antibiotics and immune attack. Bacterial infections involve distinct pathogenic mechanisms specific to gram-positive and gram-negative species, including adhesins such as pili and flagella, protective polysaccharide capsules, invasive hydrolytic enzymes, and potent exotoxins or endotoxins that trigger severe inflammatory responses leading to sepsis and septic shock. Viral pathogens establish infection through replication cycles and latency establishment, exemplified by influenza viruses that accumulate mutations through antigenic drift or undergo genetic recombination through antigenic shift, alongside herpesviruses establishing lifelong latency, human immunodeficiency virus destroying immune cells, human papillomavirus causing malignant transformation, and hepatitis viruses targeting the liver. Fungal infections span superficial dermatophyte colonization of skin and nails to invasive systemic infections caused by dimorphic fungi that shift morphology between environmental and pathogenic forms, while parasitic infections involve protozoal pathogens and multicellular helminths with complex transmission cycles. Growing antimicrobial resistance threatens clinical outcomes through enzymatic inactivation of antibiotics, active efflux pump expulsion of drugs, genetic alteration of drug targets, and horizontal gene transfer spreading resistance determinants among pathogenic populations. Vaccination strategies activate durable protective immunity through active immunization with selected antigens or provide immediate but temporary protection through passive immunotherapy using preformed antibodies administered directly to patients.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥